SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-034195
Filing Date
2024-08-01
Accepted
2024-08-01 16:43:21
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vir-20240630.htm   iXBRL 10-Q 1395827
2 EX-31.1 a20240801-q210qex311.htm EX-31.1 10787
3 EX-32.1 a20240801-q210qex321.htm EX-32.1 6752
  Complete submission text file 0001628280-24-034195.txt   6428833

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20240630.xsd EX-101.SCH 45807
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vir-20240630_cal.xml EX-101.CAL 69091
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20240630_def.xml EX-101.DEF 206700
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20240630_lab.xml EX-101.LAB 583474
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20240630_pre.xml EX-101.PRE 398735
72 EXTRACTED XBRL INSTANCE DOCUMENT vir-20240630_htm.xml XML 736060
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 241167439
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)